Losartan may cause hyperkalemia in patients with chronic renal failure and in those receiving potassium-sparing diuretics or potassium supplements. Serum potassium and renal function must be monitored.
Rhabdomyolysis, anaphylactic reactions, angioedema with swelling of the larynx and glottis causing airway obstruction and/or swelling of the face, lips, pharynx and/or tongue have been reported rarely in patients treated with losartan. The drug appears less likely to cause cough and angioneurotic edema than ACE inhibitors.
Losartan has a uricosuric effect after single or multiple doses in salt-depleted or salt-loaded normotensive patients, sodium-depleted patients with essential hypertension, and hypertensive patients with intrinsic renal disease.
View ADR Monitoring Form